JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265590

Anti-CDK1 antibody [BLR085G]

Be the first to review this product! Submit a review

|

(13 Publications)

Rabbit Recombinant Monoclonal CDK1 antibody. Suitable for ICC, IP, WB, IHC-P, Flow Cyt and reacts with Human, Mouse samples. Cited in 13 publications. Immunogen corresponding to Synthetic Peptide within Human CDK1 aa 1-50.

View Alternative Names

CDC2, CDC28A, CDKN1, P34CDC2, CDK1, Cyclin-dependent kinase 1, Cell division control protein 2 homolog, Cell division protein kinase 1, p34 protein kinase

7 Images
Immunocytochemistry - Anti-CDK1 antibody [BLR085G] (AB265590)
  • ICC

Supplier Data

Immunocytochemistry - Anti-CDK1 antibody [BLR085G] (AB265590)

Immunocytochemical analysis of formalin-fixed, paraffin-embedded molt4 cells labeling CDK1 with ab265590 at 1/100 dilution. Detection : DAB.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 antibody [BLR085G] (AB265590)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 antibody [BLR085G] (AB265590)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded human prostate carcinoma tissue labeling CDK1 with ab265590 at 1/100 dilution. Detection : DAB.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 antibody [BLR085G] (AB265590)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 antibody [BLR085G] (AB265590)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded human breast carcinoma tissue labeling CDK1 with ab265590 at 1/100 dilution. Detection : DAB.

Flow Cytometry - Anti-CDK1 antibody [BLR085G] (AB265590)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-CDK1 antibody [BLR085G] (AB265590)

Flow cytometry overlay histogram of 4% formaldehyde fixed Jurkat cells permeabilized with 90% methanol labeling human CDK1 with ab265590 at 1 µl per 1 x 10^6 cells (shaded) compared with a Isotype control (unshaded). Secondary antibody details : DyLight® 488-conjugated goat anti-rabbit IgG (ab96883).

Immunoprecipitation - Anti-CDK1 antibody [BLR085G] (AB265590)
  • IP

Supplier Data

Immunoprecipitation - Anti-CDK1 antibody [BLR085G] (AB265590)

CDK1 was immunoprecipitated from 1mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab265590 at 20 μl/mg lysate. Western blot was performed from the immunoprecipitate using ab265590 at 1/1000 dilution.

Lane 1 : ab265590 IP in HeLa whole cell lysate.
Lane 2 : Control IgG.

Exposure time : 10 secs.

Cells prepared using NETN lysis buffer.

All lanes:

Immunoprecipitation - Anti-CDK1 antibody [BLR085G] (ab265590)

Predicted band size: 34 kDa

false

Western blot - Anti-CDK1 antibody [BLR085G] (AB265590)
  • WB

Supplier Data

Western blot - Anti-CDK1 antibody [BLR085G] (AB265590)

Cells prepared using NETN lysis buffer.

All lanes:

Western blot - Anti-CDK1 antibody [BLR085G] (ab265590) at 1/1000 dilution

Lane 1:

HeLa whole cell lysate at 50 µg

Lane 2:

U-2 OS whole cell lysate at 50 µg

Lane 3:

K562 whole cell lysate at 50 µg

Lane 4:

HEK-293T whole cell lysate at 50 µg

Lane 5:

A549 whole cell lysate at 50 µg

Lane 6:

Jurkat whole cell lysate at 50 µg

Lane 7:

MCF7 whole cell lysate at 50 µg

Lane 8:

RKO whole cell lysate at 50 µg

Secondary

All lanes:

HRP-conjugated goat anti-rabbit IgG

Predicted band size: 34 kDa

false

Exposure time: 30s

Western blot - Anti-CDK1 antibody [BLR085G] (AB265590)
  • WB

Supplier Data

Western blot - Anti-CDK1 antibody [BLR085G] (AB265590)

Cells prepared using NETN lysis buffer.

All lanes:

Western blot - Anti-CDK1 antibody [BLR085G] (ab265590) at 1/1000 dilution

Lane 1:

BW 5147.3 whole cell lysate at 50 µg

Lane 2:

F9 whole cell lysate at 50 µg

Secondary

All lanes:

HRP conjugated goat anti-rabbit IgG

Predicted band size: 34 kDa

false

Exposure time: 3min

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

BLR085G

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

IHC-P, WB, Flow Cyt, IP, ICC

applications

Immunogen

Synthetic Peptide within Human CDK1 aa 1-50. The exact immunogen used to generate this antibody is proprietary information.

P06493

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p>20 μl/1 mg lysate</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p>Epitope retrieval with citrate buffer pH6.0 is recommended for FFPE tissue sections.</p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µL for 10^6 Cells", "FlowCyt-species-notes": "<p></p>" }, "Mouse": { "ICC-species-checked": "guaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "" } } }

Product details

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

This product is sold under License from Bethyl Laboratories, Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Purification notes
Purified from TCS.
Storage buffer
pH: 7.8 - 8.6 Preservative: 0.09% Sodium azide Constituents: 98% Borate buffered saline, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition via association with multiple interphase cyclins (PubMed : 16407259, PubMed : 16933150, PubMed : 17459720, PubMed : 18356527, PubMed : 19509060, PubMed : 19917720, PubMed : 20171170, PubMed : 20935635, PubMed : 20937773, PubMed : 21063390, PubMed : 2188730, PubMed : 23355470, PubMed : 2344612, PubMed : 23601106, PubMed : 23602554, PubMed : 25556658, PubMed : 26829474, PubMed : 27814491, PubMed : 30139873, PubMed : 30704899, PubMed : 40440427). Phosphorylates PARVA/actopaxin, APC, AMPH, APC, ASB7, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CENPA, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, UHRF1, KAT5, LMNA, LMNB, LBR, MKI67, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MLST8, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, TPPP, UL40/R2, RAB4A, RAP1GAP, RBBP8/CtIP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1, SAMHD1, SIRT2, CGAS and RUNX2 (PubMed : 16407259, PubMed : 16933150, PubMed : 17459720, PubMed : 18356527, PubMed : 19202191, PubMed : 19509060, PubMed : 19917720, PubMed : 20171170, PubMed : 20935635, PubMed : 20937773, PubMed : 21063390, PubMed : 2188730, PubMed : 22411829, PubMed : 23355470, PubMed : 2344612, PubMed : 23601106, PubMed : 23602554, PubMed : 25012651, PubMed : 25556658, PubMed : 26829474, PubMed : 27814491, PubMed : 30704899, PubMed : 32351706, PubMed : 34741373, PubMed : 40440427). CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs (PubMed : 18480403, PubMed : 20360007). Essential for early stages of embryonic development (PubMed : 18480403, PubMed : 20360007). During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation (PubMed : 18480403, PubMed : 20360007, PubMed : 2188730, PubMed : 2344612, PubMed : 30139873). Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis (PubMed : 18480403, PubMed : 20360007). Phosphorylates KRT5 during prometaphase and metaphase (By similarity). Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair (PubMed : 20360007). Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression (PubMed : 20395957). Catalyzes lamin (LMNA, LMNB1 and LMNB2) phosphorylation at the onset of mitosis, promoting nuclear envelope breakdown (PubMed : 2188730, PubMed : 2344612, PubMed : 37788673). In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons (PubMed : 18356527). The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis (PubMed : 16371510). NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation (PubMed : 19509060). In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis (PubMed : 20171170). The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis (PubMed : 19917720). In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis (PubMed : 20937773). This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes (PubMed : 20937773). EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing (PubMed : 20935635). CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration (By similarity). CDK1-cyclin-B complex phosphorylates NCKAP5L and mediates its dissociation from centrosomes during mitosis (PubMed : 26549230). Regulates the amplitude of the cyclic expression of the core clock gene BMAL1 by phosphorylating its transcriptional repressor NR1D1, and this phosphorylation is necessary for SCF(FBXW7)-mediated ubiquitination and proteasomal degradation of NR1D1 (PubMed : 27238018). Phosphorylates EML3 at 'Thr-881' which is essential for its interaction with HAUS augmin-like complex and TUBG1 (PubMed : 30723163). Phosphorylates CGAS during mitosis, leading to its inhibition, thereby preventing CGAS activation by self DNA during mitosis (PubMed : 32351706). Phosphorylates SKA3 on multiple sites during mitosis which promotes SKA3 binding to the NDC80 complex and anchoring of the SKA complex to kinetochores, to enable stable attachment of mitotic spindle microtubules to kinetochores (PubMed : 28479321, PubMed : 31804178, PubMed : 32491969).. (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry.
See full target information CDK1

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Cancer cell international 25:325 PubMed41044576

2025

Kaempferol triggers cellular senescence via CDK1 ubiquitination in HCC cells.

Applications

Unspecified application

Species

Unspecified reactive species

Damin Liang,Min Tian,Guomei Hu,Yu Zhang,Lunyou Zhang,Juqi Chen,Xin Shen,Huayong Jian,Peng Tian,Tingchao Li,Xiaoju Cheng

PloS one 20:e0328698 PubMed40720499

2025

Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Xinlei Li,Yan Liu,Zhiqian Wang,Xiaocui Bu,Yu Wang,Wei Zhang,Peng Zhao

Cell death discovery 11:130 PubMed40175357

2025

Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype.

Applications

Unspecified application

Species

Unspecified reactive species

Gang Liu,Yan Zhang,Zhen Cao,Zhanwei Zhao

Cell biology and toxicology 41:16 PubMed39724454

2024

Targeting CDK1 and copper homeostasis in breast cancer via a nanopolymer drug delivery system.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Shang,Lisi Zhu,Yan Li,Chengyang Song,Xiaodan Liu

Oncology letters 29:61 PubMed39611064

2024

Knockdown of CENPF induces cell cycle arrest and inhibits epithelial‑mesenchymal transition progression in glioma.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Li,Lei Liu,Gang Zong,Zhihao Yang,Deran Zhang,Bing Zhao

Biomedical chromatography : BMC 38:e6023 PubMed39390901

2024

Huangqi-Guizhi-Wuwutang protects against oligospermia in mice by promoting the proliferation of spermatogenic stem cells: A comprehensive study using HPLC-Q-TOF/MS and experimental pharmacology.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Zhao,Jinru Wu,Xiangbin Li,Lin Zheng,Qiugu Chen,Shangbin Zhang,Jianping Chen

Cancer medicine 13:e70104 PubMed39171503

2024

Predictive biomarkers for metachronous gastric cancer development after endoscopic resection of early gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Bokyung Kim,Harim Chun,Jongwon Lee,Miree Park,Yoonjin Kwak,Jung Mogg Kim,Sang Gyun Kim,Ji Kon Ryu,Jungmin Choi,Soo-Jeong Cho

Cell chemical biology 31:1490-1502.e42 PubMed39116881

2024

Regulated induced proximity targeting chimeras-RIPTACs-A heterobifunctional small molecule strategy for cancer selective therapies.

Applications

Unspecified application

Species

Unspecified reactive species

Kanak Raina,Chris D Forbes,Rebecca Stronk,Jonathan P Rappi,Kyle J Eastman,Nilesh Zaware,Xinheng Yu,Hao Li,Amit Bhardwaj,Samuel W Gerritz,Mia Forgione,Abigail Hundt,Madeline P King,Zoe M Posner,Allison D Correia,Andrew McGovern,David E Puleo,Rebekka Chenard,James J Mousseau,J Ignacio Vergara,Ethan Garvin,Jennifer Macaluso,Michael Martin,Kyle Bassoli,Kelli Jones,Marco Garcia,Katia Howard,Madeleine Yaggi,Levi M Smith,Jinshan M Chen,Andrew B Mayfield,Cesar A De Leon,John Hines,Katherine J Kayser-Bricker,Craig M Crews

Surgery open science 20:106-115 PubMed39021615

2024

Development and validation of a mouse model to investigate post surgical pain after laparotomy.

Applications

Unspecified application

Species

Unspecified reactive species

Juan Martinez,Thomas Maisey,Nicola Ingram,Nikil Kapur,Paul A Beales,David G Jayne

Breast cancer research : BCR 24:92 PubMed36539893

2022

Ring finger protein 126 promotes breast cancer metastasis and serves as a potential target to improve the therapeutic sensitivity of ATR inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

You Pan,Yuchao Yang,Rong Huang,Huawei Yang,Qinghua Huang,Yinan Ji,Jingxing Dai,Kun Qiao,Wei Tang,Longgui Xie,Ming Yin,Jun Ouyang,Shipeng Ning,Danke Su
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com